Clinical impact of ERG and PTEN status in prostate cancer patients underwent radical prostatectomy.


Journal

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
ISSN: 2282-4197
Titre abrégé: Arch Ital Urol Androl
Pays: Italy
ID NLM: 9308247

Informations de publication

Date de publication:
27 Dec 2022
Historique:
received: 22 09 2022
accepted: 24 09 2022
entrez: 28 12 2022
pubmed: 29 12 2022
medline: 31 12 2022
Statut: epublish

Résumé

Phosphate and tensin homolog gene (PTEN) acts as a regulator of PI3-KAkt molecular pathway. ETS Related gene (ERG), an oncogene located in chromosome 21q22.2, is involved in prostate cancer (PCa) by serine 2 (TMPRSS2), a protein encoded by TMPRSS2 gene. The aim of this study is to evaluate the clinical impact of PTEN loss and ERG rearrangement in terms of oncologic results in patients diagnosed with localized PCa who underwent radical prostatectomy. Prospective data were collected from a total of 74 patients who underwent open radical retropubic prostatectomy for localized PCa and immunohistochemical study was performed in tissue samples. The primary antibodies for anti-ERG antibody as well as anti-PTEN antibody were obtained from DAKO. ERG was considered positive if at least 20% of the evaluated cells were stained at least with medium intensity. PTEN protein loss was considered when the intensity of cytoplasmic and nuclear staining was mild or entirely negative across > 10% of tumor cells. Homogenous loss of PTEN was associated with higher clinical International Society of Urological Pathology (ISUP) grade (p = 0.018) while no statistical significant association was present regarding the presence of ERG rearrangement with either ISUPc or ISUPp. After a median follow up of 34 months, 24 patients developed biochemical recurrence. No statistical significant correlation of ERG status with biochemical recurrence was noted while PTEN was associated with biochemical recurrence development in a statistical significant way. Lastly the combination of PTEN loss with ERG rearrangement presence was detected more often in higher ISUPc and ISUPp as well as biochemical recurrence development, although in a non statistical significant way. Homogenous and heterogenous PTEN loss was associated with biochemical recurrence. No association of ERG and biochemical recurrence was noted. The combination of PTEN loss and ERG rearrangement presented a trend for higher ISUPc and ISUPp as well as biochemical recurrence but not in a statistical significant way.

Identifiants

pubmed: 36576468
doi: 10.4081/aiua.2022.4.390
doi:

Substances chimiques

Transcriptional Regulator ERG 0
PTEN Phosphohydrolase EC 3.1.3.67
Biomarkers, Tumor 0
ERG protein, human 0
PTEN protein, human EC 3.1.3.67

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

390-395

Auteurs

Charalampos Fragkoulis (C)

Department of Urology, General Hospital of Athens "G. Gennimatas", Athens. harisfrag@yahoo.gr.

Ioannis Glykas (I)

Department of Urology, General Hospital of Athens "G. Gennimatas", Athens. giannis.glykas@gmail.com.

Lazaros Tzelves (L)

2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens. lazarostzelves@gmail.com.

Panagiotis Velissarios Stamatakos (PV)

Department of Urology, General Hospital of Athens "G. Gennimatas", Athens. pvstamatakos@gmail.com.

Georgios Papadopoulos (G)

Department of Urology, General Hospital of Athens "G. Gennimatas", Athens. gipapadopoulos@yahoo.gr.

Georgios Stathouros (G)

Department of Urology, General Hospital of Athens "G. Gennimatas", Athens. gstathouros@yahoo.gr.

Athanasios Dellis (A)

1st Department of Urology, School of Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens. aedellis@gmail.com.

Konstantinos Ntoumas (K)

Department of Urology, General Hospital of Athens "G. Gennimatas", Athens. ntoumask@yahoo.com.

Akrivi Kostopoulou (A)

Department of Pathology, General Hospital of Athens "G. Gennimatas", Athens. akrivikostopoulou@hotmail.com.

Charalampos Deliveliotis (C)

2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens. chdeliveli@gmail.com.

Athanasios Papatsoris (A)

2nd Department of Urology, School of Medicine, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens. agpapatsoris@yahoo.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH